Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study.

Saved in:
Bibliographic Details
Title: Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study.
Authors: Wu Y; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Yuan X; Department of Hematology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Chen L; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China., Lai X; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Liu L; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Yang L; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Shi J; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Yu J; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Zhao Y; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Ouyang G; Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China., Ni L; Department of Hematology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China., Xiao H; Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China., Xu Y; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Tang L; Department of Hematology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China., Zhu P; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Cai Z; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Huang H; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Lu Y; Department of Hematology, The Affiliated Peoples' Hospital of Ningbo University, Ningbo, China., Luo Y; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. luoyijr@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. luoyijr@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. luoyijr@zju.edu.cn.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2026 Apr; Vol. 61 (4), pp. 408-416. Date of Electronic Publication: 2026 Jan 09.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/s41409-025-02777-x